Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian national health service
- 30 September 2004
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 26 (9) , 1546-1561
- https://doi.org/10.1016/j.clinthera.2004.09.014
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: